Guidance Document: Part C, Division 5 of the Food and Drug Regulations “Drugs for Clinical Trials Involving Human Subjects” (GUI-0100)

Written by Barbara Brown



Health Canada | N2 News



August 27, 2019

Health Canada has released their new guidance document for clinical trial researchers to comply with Part C, Div 5 of the Food & Drug Regulations. Review the document here.

Register for the 2023 N2 Eastern Regional Meeting!

Sep 15, 2023

Registration for the 2023 N2 Eastern Regional Meeting is now open! Register today View the agenda here.

Message from N2

Sep 5, 2023

The following message is shared together with Karen Arts’s family. With profound sadness, we share the news that Karen...

Registration for the Atlantic Regional Meeting is Now Open!

Sep 5, 2023

Register for this event Organized in collaboration with Nova Scotia Health Authority and the Atlantic Clinical Trials...